Skip to main content

Published locations for HR+/HER2− BC: Adjuvant abemaciclib+ET shows sustained positive benefit-risk profile

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. HR+/HER2− BC: Adjuvant abemaciclib+ET shows sustained positive benefit-risk profile

User login

  • Reset your password
  • /content/hr/her2-bc-adjuvant-abemaciclibet-shows-sustained-positive-benefit-risk-profile
  • /hematology-oncology/article/260232/breast-cancer/hr/her2-bc-adjuvant-abemaciclibet-shows-sustained
  • /breast-cancer-icymi/article/260232/breast-cancer/hr/her2-bc-adjuvant-abemaciclibet-shows-sustained